Abstract:In this work, we designed small molecules YG-1 and YG-2 derived from molecule Thioflavin-T (ThT) containing structural moieties targeting Cu(I). To realize the purpose of Cu(I) binding, we eliminate the methyl group of ThT molecule and incorporate a nitrogen atom instead of sulfur atom. The imine in benzimidole is expected to coordinate Cu(I) effectively. This strategy is aiming at inhibiting the toxicity redox cycle and protecting cells. Using UV absorption spectroscopy, we find that YG-1 can interact with Cu(I) effectively, but not with Cu(II). ESI-MS further characterized the interactions between YG-1/2 and Cu(I) in forms of YG-1/2-Cu(I)-YG-1/2 and YG-1/2-Cu(I)-YG-1/2-Cu(I)-YG-1/2. Focusing on the peaks of complexes observed from the ESI-MS results, we calculate the binding motifs of Cu(I) to YG-1/2 by MD simulation. In particular, we study all the five possible symmetric modes of YG-1 and YG-2 respectively, which are supposed to be more stable than asymmetric modes. The simulation results show that the mode with Cu(I) binding to the imine in benzimidole of YG-1/2 in a linear geometry is the most stable structure with the lowest energy (-0.229 and -0.232 Hartree for YG-1 and YG-2 respectively). As reducing the production of ROS is an important pathway to alleviate the copper-induced A beta 1-40 cytotoxicity, we test the effects of YG-1/2 on eliminating ROS production using 3-coumarin carboxylic acid (3-CCA) fluorescence spectroscopy, and find that YG-1/2 can block ROS production almost completely. Finally, we examine the cellular protective effects of YG-1 and YG-2 against the toxicity of A beta 1-40-Cu(I) by 3-(4,5-dimethyl-2-thiaz-oyl)-2,5-diphenyl-tetrazolium bromide(MTT) assay. Experimental results show that YG-1/2 can alleviate the Cu(I)-induced A beta 1-40 toxicity and increase cell viability. Up until now, researchers have devoted many efforts to prevent copper-mediated ROS toxicity. However, few attempts have been made to treat protein-misfolding diseases by targeting Cu(I) and blocking the copper redox cycle. The designed molecules YG-1/2 in this work are able to capture Cu(I) from participating further reactions in the protein-copper redox cycle and prohibit the generation of ROS. This finding may lead to a new therapeutic strategy for treating copper-mediated protein misfolding diseases.

Tripeptide GGH as the Inhibitor of Copper-Amyloid-β-Mediated Redox Reaction and Toxicity

Guluronic acid disaccharide inhibits reactive oxygen species production and amyloid-β oligomer formation

Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity

Guluronic acid can inhibit copper(II) and amyloid − β peptide coordination and reduce copper-related reactive oxygen species formation associated with Alzheimer's disease

The mechanism for heme to prevent Aβ 1–40 aggregation and its cytotoxicity

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits Β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

Copper catalyzed oxidation of alzheimer A beta

Next-generation Cu(II) selective peptide shuttles prevent Cu(Aβ)-induced toxicity and microglial activation in organotypic hippocampal slices

The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation

Homocysteine Potentiates Copper‐ and Amyloid Beta Peptide‐mediated Toxicity in Primary Neuronal Cultures: Possible Risk Factors in the Alzheimer's‐type Neurodegenerative Pathways

A Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu2+-Mediated Aβ Aggregation

Effects of Cyclen and Cyclam on Zinc(ii)- and Copper(ii)-Induced Amyloid Beta-Peptide Aggregation and Neurotoxicity.

The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human Astrocytes

Bifunctional Copper Chelators Capable of Reducing Aβ Aggregation and Aβ-Induced Oxidative Stress

Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

A cocktail of Cu 2+ - and Zn 2+ -peptoid-based chelators can stop ROS formation for Alzheimer's disease therapy

Sequestration of Copper from Β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents*

Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.

Investigation on Small Molecules Targeting Cu(I) Preventing Copper-Mediated Neurotoxicity

Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer's Disease Context